371
Participants
Start Date
January 31, 2004
Primary Completion Date
January 31, 2008
Study Completion Date
June 30, 2009
Engerix-B 20 mcg
A single dose of 1 mL (20 mcg/mL) will be administered in the deltoid muscle at Entry, Weeks 4 and 24.
Engerix-B 40 mcg
A single dose of 2 mL (20 mcg/mL) will be administered in the deltoid muscle at Entry, Week 4 and 24.
Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg
"Arm 3: 720 EIA HAV Ag, 20 mcg HBsAg/ml:~A single dose of 1 mL will be administered in the deltoid muscle."
Harriet Shezi Childrens Clinic Chris Hani Baragwanth Hospital, Johannesburg
Tygerberg Hospital, Bellville
Children's Hosp Natinal Med Center, Washington D.C.
Tulane Med Center, New Orleans
Childrens Hosp of Los Angeles, Los Angeles
University of California at San Francisco, San Francisco
Ippmg-Ufrj, Rio de Janeiro
Federal University of Minas Gerais, Belo Horizonte
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto/USP, Ribeirão Preto
Instituto de Infectologia Emilio Ribas, São Paulo
Hospital dos Sevidores do Estado, Rio de Janeiro
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of North Carolina, Chapel Hill
OTHER